About SolasCure
SolasCure is a company based in Cardiff (United Kingdom) founded in 2017.. SolasCure has raised $34.12 million across 4 funding rounds from investors including Brain Biotech, Development Bank of Wales and Eva Pharma. The company has 11 employees as of July 31, 2021. SolasCure offers products and services including Aurase Wound Gel. SolasCure operates in a competitive market with competitors including BioMonde, EZ Debride, XSONX and Regenerative Wound Therapies, among others.
- Headquarter Cardiff, United Kingdom
- Employees 11 as on 31 Jul, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Solascure Limited
- Date of Incorporation 20 Jun, 2017
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$34.12 M (USD)
in 4 rounds
-
Latest Funding Round
$514.76 K (USD), Grant
Mar 20, 2024
-
Investors
Brain Biotech
& 9 more
-
Employee Count
11
as on Jul 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SolasCure
SolasCure offers a comprehensive portfolio of products and services, including Aurase Wound Gel. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enzymatic gel for debriding chronic wounds and promoting healing.
Unlock access to complete
Funding Insights of SolasCure
SolasCure has successfully raised a total of $34.12M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $514.76 thousand completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $514,759
-
First Round
First Round
(10 Aug 2021)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Grant - SolasCure | Valuation |
investors |
|
| Mar, 2023 | Amount | Series B - SolasCure | Valuation | Seneca | |
| Jun, 2022 | Amount | Grant - SolasCure | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SolasCure
SolasCure has secured backing from 10 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Brain Biotech, Development Bank of Wales and Eva Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Provider of equity funding and business & property development loans
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SolasCure
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SolasCure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Solascure Comparisons
Competitors of SolasCure
SolasCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioMonde, EZ Debride, XSONX and Regenerative Wound Therapies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Larva therapy is manufactured for debridement of non-healing wounds.
|
|
| domain | founded_year | HQ Location |
A patent-pending wound debridement tool is developed by EZ Debride.
|
|
| domain | founded_year | HQ Location |
Develops wound hygiene systems using micro-vibrational technology to enhance healing.
|
|
| domain | founded_year | HQ Location |
Offers advanced wound management through innovative medical devices for healthcare.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Solascure
Frequently Asked Questions about SolasCure
When was SolasCure founded?
SolasCure was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Where is SolasCure located?
SolasCure is headquartered in Cardiff, United Kingdom. It is registered at Cardiff, Wales, United Kingdom.
Is SolasCure a funded company?
SolasCure is a funded company, having raised a total of $34.12M across 4 funding rounds to date.
How many employees does SolasCure have?
As of Jul 31, 2021, the latest employee count at SolasCure is 11.
What does SolasCure do?
SolasCure was founded in 2017 in Cardiff, United Kingdom. Products for wound care are developed within the medical biotechnology sector. Operations center on innovative hydrogels for debridement and healing. The primary product, Aurase, incorporates an active enzyme that has been isolated and cloned from medical maggots traditionally used for wound cleaning. Focus remains on clinical applications for chronic and acute wounds.
Who are the top competitors of SolasCure?
SolasCure's top competitors include BioMonde, EZ Debride and XSONX.
What products or services does SolasCure offer?
SolasCure offers Aurase Wound Gel.
Who are SolasCure's investors?
SolasCure has 10 investors. Key investors include Brain Biotech, Development Bank of Wales, Eva Pharma, Seneca Partners, and Jonathan Milner.